Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma

Liver Transplantation

Volumn 18, Issue 5, 2012, Pages 594-601

  Panjala, Chakri ^a   Nguyen, Justin H ^a   Al Hajjaj, Ali N ^a   Rosser, Barry A ^a   Nakhleh, Raouf E ^a   Bridges, Mellena D ^a   Ko, Stephen J ^a   Buskirk, Steven J ^a   Kim, George P ^a   Harnois, Denise M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE SEVERITY; DONOR SELECTION; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; INOPERABLE CANCER; LIVER TRANSPLANTATION; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMORADIOTHERAPY; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; TUMOR BURDEN;

EID: 84860172740     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22462     Document Type: Article

References (30)

1. Shaib Y, El-Serag HB,. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125.
2. Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997; 185: 429-436.
3. Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM,. Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg 1998; 5: 41-47.
4. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE,. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998; 227: 70-79.
5. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M,. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89: 1525-1531.
6. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H,. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999; 6: 108-116.
7. Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF, Belghiti J,. Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 1999; 6: 122-127.
8. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473.
9. Nagorney DM, Kendrick ML,. Hepatic resection in the treatment of hilar cholangiocarcinoma. Adv Surg 2006; 40: 159-171.
10. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755-762.
11. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999; 230: 808-818.
12. Pascher A, Jonas S, Neuhaus P,. Intrahepatic cholangiocarcinoma: indication for transplantation. J Hepatobiliary Pancreat Surg 2003; 10: 282-287.
13. Weimann A, Varnholt H, Schlitt HJ, Lang H, Flemming P, Hustedt C, et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg 2000; 87: 1182-1187.
14. Meyer CG, Penn I, James L,. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000; 69: 1633-1637.
15. Iwatsuki S, Todo S, Marsh JW, Madariaga JR, Lee RG, Dvorchik I, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187: 358-364.
16. Kaiser GM, Sotiropoulos GC, Jauch KW, Löhe F, Hirner A, Kalff JC, et al. Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc 2008; 40: 3191-3193.
17. Sotiropoulos GC, Kaiser GM, Lang H, Molmenti EP, Beckebaum S, Fouzas I, et al. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience. Transplant Proc 2008; 40: 3194-3195.
18. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002; 2: 774-779.
19. Rosen CB, Heimbach JK, Gores GJ,. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) 2008; 10: 186-189.
20. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM,. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378.
21. Nguyen JH, Dickson RC, Harnois DM,. A decade of liver transplantation at Mayo Clinic in Florida. Clin Transpl 2008: 127-135.
22. Stauffer JA, Steers JL, Bonatti H, Dougherty MK, Aranda-Michel J, Dickson RC, et al. Liver transplantation and pancreatic resection: a single-center experience and a review of the literature. Liver Transpl 2009; 15: 1728-1737.
23. Nguyen JH,. Distinguishing between parenchymal and anastomotic leakage at duct-to-mucosa pancreatic reconstruction in pancreaticoduodenectomy. World J Gastroenterol 2008; 14: 6648-6654.
24. Renshaw. K. Malignant neoplasms of the extrahepatic biliary ducts. Annals of Surgery. 1922;76:205-21.
25. Alden ME, Mohiuddin M,. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys 1994; 28: 945-951.
26. Foo ML, Gunderson LL, Bender CE, Buskirk SJ,. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 1997; 39: 929-935.
27. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82: 1703-1707.
28. Panjala C, Nguyen JH, Nakhleh RE, Harnois DM,. The impact of neoadjuvant chemoradiation on the tumor burden prior to liver transplantation in unresectable non-metastatic cholangiocarcinoma [abstract]. Hepatology 2009; 50 (suppl 4): 1078A.
29. Panjala C, Nguyen JH, Nakhleh RE, Harnois DM,. Pre-operative staging conundrum of cholangiocarcinoma and its impact on candidate selection and outcome following neo-adjuvant protocol liver transplantation [abstract]. Hepatology 2009; 50 (suppl 4): 1106A.
30. Gleeson FC, Rajan E, Levy MJ, Clain JE, Topazian MD, Harewood GC, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 2008; 67: 438-443.